603 results on '"Obara, Wataru"'
Search Results
2. A case of postoperative pancreatitis in patients with renal cell carcinoma with an inferior vena cava tumor thrombus treated by presurgical lenvatinib plus pembrolizumab
3. Impact of timing of rejection episode on cardiovascular events in living donor kidney transplantation: a multicenter retrospective study
4. Preoperative prognostic model for localized and locally advanced renal cell carcinoma: Michinoku Japan Urological Cancer Study Group
5. Quantification of escape from X chromosome inactivation with single-cell omics data reveals heterogeneity across cell types and tissues
6. Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial
7. The Clinical Validity of Urinary Pellet DNA Monitoring for the Diagnosis of Recurrent Bladder Cancer
8. Erythropoietin levels after bilateral nephrectomy for renal cell carcinoma; a case report
9. Genetic Risk Stratification of Primary Open-Angle Glaucoma in Japanese Individuals
10. Detection of anterior prostate cancer using a magnetic resonance imaging-transrectal ultrasound fusion biopsy in cases with initial biopsy and history of systematic biopsies
11. Impact of exposure on outcomes with enfortumab vedotin in patients with locally advanced or metastatic urothelial cancer.
12. MP38-04 PREDICTION OF RECURRENCE USING CASE-SPECIFIC CIRCULATING TUMOR DNA IN POSTOPERATIVE PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA
13. PD38-09 PATHOLOGICAL COMPLETE RESPONSE TO NEOADJUVANT CHEMOTHERAPY IMPROVES ANTITUMOR IMMUNE RESPONSE THROUGH REDUCTION OF REGULATOTY T CELLS IN MUSCLE-INVASIVE BLADDER CANCER
14. PD61-11 INITIAL EXPERIENCE OF ROBOT-ASSISTED RADICAL PROSTATECTOMY USING HINOTORI SURGICAL ROBOT SYSTEM
15. PD16-08 ELUCIDATION OF THE INTERPLAY BETWEEN PHOSPHOLIPID BYOSYNTHESIS AND OXIDATIVE STRESS IN THE PATHOGENESIS OF RENAL CELL CARCINOMA
16. PD41-06 EVALUATION OF THE TUMOR MICROENVIRONMENT OF UPPER TRACT UROTHELIAL CARCINOMA USING MULTIPLEX FLUORESCENCE IMMUNOHISTOCHEMISTRY
17. MP05-19 POLYGENETIC RISK SCORE FOR PROSTATE CANCER IS ASSOCIATED WITH LIPOPOLYSACCHARIDE PATHWAY IN GUT MICROBIOME
18. Site-specific patterns of early response to nivolumab plus ipilimumab therapy in advanced renal cell carcinoma patients compared with tyrosine-kinase inhibitors
19. Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi‑institutional retrospective study
20. Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy setting
21. Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi-institutional retrospective study
22. Emphysematous pyelonephritis diagnosed by acute changes detected via computed tomography: A case report.
23. Supplementary Tables S1-S5 from TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma
24. Data from TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma
25. Supplementary Legends from TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma
26. Supplementary Figure S1 from TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma
27. WCN24-244 The utility of Indoxyl sulfate as a biomarker for early detection of CKD
28. WCN24-866 THE TYPE OF HEPARIN USED FOR ANTICOAGULATION IN PATIENTS ON HEMODIALYSIS AFFECTS CARNITINE METABOLISM
29. Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era
30. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
31. Common and rare genetic variants predisposing females to unexplained recurrent pregnancy loss.
32. Comparison of outcomes in kidney transplantations involving blood-related and non-blood-related living donors: a multicenter retrospective study by the Michinoku renal transplant network.
33. Successful treatment of eosinophilia associated with dialysis‐related renal cancer with radical nephrectomy.
34. Abnormal carnitine metabolism in hemodialysis patients on different anticoagulants.
35. Sunitinib Versus Sorafenib as Initial Targeted Therapy for mCC-RCC With Favorable/Intermediate Risk: Multicenter Randomized Trial CROSS-J-RCC
36. Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
37. Parenchymal renal rupture due to an obstructive ureteric calculus in an incompletely duplicated renal pelvis and ureter
38. Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review
39. Pathological complete response to neoadjuvant chemotherapy may improve antitumor immune response via reduction of regulatory T cells in muscle-invasive bladder cancer
40. A case of severe ureteral injury repaired by renal autotransplantation with an iliac vein patch using bovine pericardium
41. A case of complete response to avelumab plus axitinib combination therapy for metastatic clear cell renal cell carcinoma in a kidney undergoing dialysis
42. Avelumab plus axitinib for translocation renal cell carcinoma: A case series and literature review
43. Abnormal carnitine metabolism in hemodialysis patients on different anticoagulants
44. Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma
45. Mitochondrial DNA Variants at Low-Level Heteroplasmy and Decreased Copy Numbers in Chronic Kidney Disease (CKD) Tissues with Kidney Cancer
46. TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma
47. Durable Response After Combination Therapy With Enfortumab Vedotin and Radiotherapy in Metastatic Urothelial Carcinoma: A Report of Two Cases
48. Metastatic bladder cancer forming a sigmoidorectal fistula after enfortumab vedotin therapy: a case report
49. Improvement of three-dimensional motion sickness using a virtual reality simulator for robot-assisted surgery in undergraduate medical students: A prospective observational study
50. Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.